Searle et al., 2022)
Similarly, the frequency of PT-141 observed side effects are generally dose dependent, with an increased incidence of flushing, nausea, noxious aftertaste, post-nasal drip, headache, rhinorrhea, and vomiting at higher doses
Warnings There are some known risks stated in the prescribing information for these drugs
Below is the complete reference table: Source: FDA prescribing information
Common symptoms include: Nausea (reported in up to 44% of patients in clinical trials) Vomiting Diarrhoea Constipation Abdominal pain and bloating Berberine similarly causes gastrointestinal disturbances in many users, including diarrhoea, constipation, flatulence, and abdominal cramping
Studies involving the specific deletion of GLUT4 in adipose tissue of mice have shown a strong correlation between RBP4, obesity, and T2DM (Gasmi et al., 2024)